Soluble urokinase-type plasminogen activator receptor strongly predicts global mortality in acute heart failure patients: insight from the STADE-HF registry published in Future Science The objective of this new study was to evaluate the prognosis [...]
suPAR Knowledge Hub
suPAR is extensively described on this website.
Please find here a selection of articles and basic information about suPAR.
You can search for a specific topic below, or choose a category of information.
Soluble urokinase plasminogen activator receptor as a decision marker for early discharge of patients with COVID-19 symptoms in the emergency department published in The Journal of Emergency Medicine A newly published paper written ED [...]
An open label trial of anakinra to prevent respiratory failure in COVID-19 The management of pneumonia caused by SARS-CoV-2 should rely on early recognition of the risk for progression to severe respiratory failure (SRF) and its prevention. The [...]
"Prognostic value of soluble urokinase plasminogen activator receptor in patients presenting to the Emergency Department with chest pain suggestive of acute coronary syndrome", published in Clinical Biochemistry This study aimed to evaluate the early prognostic value of suPAR [...]
El Complejo Asistencial Universitario de Salamanca ha sido uno de los primeros hospitales en España en introducir suPAR en su catálogo de pruebas. A finales del año pasado hicieron un interesante trabajo sobre cómo suPAR puede ayudar a mejorar [...]
The Salamanca University Assistance Complex has been one of the first hospitals in Spain to introduce suPAR in its test catalog. At the end of last year they conducted an interesting study on how suPAR can help improve triage, [...]